Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB09062ExperimentalSmall molecule
Cefminox (INN) is a second generation cephalosporin antibiotic. It is approved for use in Japan.
- Mechanism
- Curator reviewed · 1 reference
Cefminox is a β-lactam cephalosporin that binds and inactivates bacterial penicillin-binding proteins (PBPs), inhibiting peptidoglycan cell-wall synthesis.
- Formula / weight
- C16H21N7O7S3 · 519.57 g/mol (avg)
- Also known as
- CMNX
Resolves to
Clinical / RWD
Structure
InChIKey
JSDXOWVAHXDYCU-VXSYNFHWSA-NSMILES[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)CSC[C@@H](N)C(O)=O)OC)C(O)=OWhat you can answer from here — as of September 13, 2026
3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Cefminox, and which of those have an active Phase 3 trial?